Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of Bioabsorbable Polydioxanone Implant and Delivery Device for Correction of Cartilaginous Septal Deviation

NCT05967169 is registered in ClinicalTrials.gov with Spirair, Inc as lead sponsor.

NCT NCT05967169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05967169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of Bioabsorbable Polydioxanone Implant and Delivery Device for Correction of Cartilaginous Septal Deviation
Lead sponsor
Spirair, Inc
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2022
Completion date
March 23, 2026
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nasal septal deviation